Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Rumor Has It: Expect Valeant Divestitures?

Executive Summary

The plagued specialty pharma has been rumored to have at least one suitor, but analysts are skeptical and expect multiple divestitures will be required if the company is going to gain back some of its losses.

Advertisement

Related Content

Takeda Closing In Again On Valeant Assets?
Valeant's Papa Lays Out Plan For Turnaround
Valeant On Upswing With Walgreens Deal
Demystifying Valeant And Philidor

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register